Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Dysstasia, Gait disturbance, Loss of personal independence in daily activities
Clinical narrative: Roughly 5 days after receiving "his" 2nd dose of the vaccine, "he" began experiencing great difficulty standing/walking; Roughly 5 days after receiving his 2nd dose of the vaccine, he began experiencing great difficulty standing/walking; "He" had gone from being able to move around free of any assistance (albeit slowly), to requiring assistance standing, walking, bathing/showering, dressing, going to the bathroom, and getting in and out of bed.; This is a spontaneous report from a contactable consumer. A 73-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201) via an unspecified route of administration in the left arm on 23Feb2021 at 09:30 (at the age of 73-years-old) as a single dose for COVID-19 immunisation. Medical history included parkinson's disease (w/Lewy body) , heart disorder(unspecified) and diabetes. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Concomitant medications included atorvastatin (MANUFACTURER UNKNOWN), quetiapine (MANUFACTURER UNKNOWN), memantine (MANUFACTURER UNKNOWN), metoprolol tartrate (MANUFACTURER UNKNOWN), carbidopa, levodopa (MANUFACTURER UNKNOWN), furosemide (MANUFACTURER UNKNOWN), lisinopril (MANUFACTURER UNKNOWN), spironolactone (MANUFACTURER UNKNOWN), insulin glargine (LANTUS), insulin aspart (NOVOLOG), cyanocobalamin (MANUFACTURER UNKNOWN), tamsulosin (MANUFACTURER UNKNOWN), melatonin (MANUFACTURER UNKNOWN), fish oil (MANUFACTURER UNKNOWN), lactobacillus acidophilus (ACIDOPHILUS PROBIOTIC), docusate sodium, senna alexandrina (SENOKOT-S), docusate sodium (STOOL SOFTENER), ubidecarenone (COQ 10) and acetylsalicylic acid (ASPIRIN), Men's One-a-day vitamin (MANUFACTURER UNKNOWN) taken for an unknown indication on an unknown date and unknown if ongoing. On 28Feb2021 at 08:00, roughly 5 days after receiving second dose of the vaccination, the patient experienced great difficulty standing/walking. The patient had gone from being able to move around free of any assistance (albeit slowly), to requiring assistance standing, walking, bathing/showering, dressing, going to the bathroom, and getting in and out of bed. The events resulted in doctor or other healthcare professional office/clinic visit. It was unknown, if therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events great difficulty standing/walking, assistance (albeit slowly), to requiring assistance standing, walking, bathing/showering, dressing, going to the bathroom, and getting in and out of bed were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.